Divis Laboratories shares declined by 2.05% to Rs 6,061.00 in Thursday's session. At 11:48 am, the stock was trading lower compared to its previous close. The company's consolidated financial ...

Divis Laboratories is reporting earnings from the most recent quarter on August 8. Wall Street analysts predict earnings per share of INR 11.98. Follow Divis Laboratories stock price in real-time here ...

Earnings call Divi’s Laboratories reported Q2 FY25 consolidated revenue of ₹2,444 crore, up 22.5% YoY and 11.2% QoQ. Profit after tax rose to ₹510 crore, up 46.6% YoY. Custom synthesis now contributes ...

Divis Laboratories' stock price is down 8 percent over the last month. Shares of Divis Laboratories rose 3 percent to Rs 6,188 on Friday, August 22, after global brokerage Citi turned upbeat on the ...

Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025. - Rediff MoneyWiz, the personal finance ...

Benchmark indices closed lower on Monday tracking weak global markets amid concerns over US President Donald Trump imposing tariffs on some of its trading partners. Stocks that were in focus include ...

Murali Krishna Divi Chairman and managing director, Divis Laboratories Age: 63 Rank in the Rich List: 45 Net Worth: $2.03 billion The Big Challenge Faced in the Last Year: Managing growth in an ...

Amid the rising volatility in the Indian equity markets, domestic brokerage firm BP Equities has shared its top picks for January 2026 on a techno-funda basis. These include names like Bharat ...

> Icon, an Ireland-based clinical research company, said it will open a new global innovation hub in the country that will create 200 new jobs. Announcement > Indian API maker Divis Laboratories ...

Divis Laboratories Ltd has informed BSE that it has had a successful inspection by the US-FDA from 16th to 20th June, 2014, without any observations, for its Unit-I at vill. Lingojigudem, Choutuppal ...

Divis Laboratories will release figures for Q3 on February 5. Wall Street analysts expect Divis Laboratories will report earnings per share of INR 16.51. Go here to watch Divis Laboratories stock ...

Earnings call Divi's Laboratories reported a 17% YoY revenue growth in Q2 FY26, driven by a record 56% contribution from custom synthesis. Margins remained resilient despite ongoing generic pricing ...